---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022615"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:21:29.110134+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tharimmune appoints Nancy Davis to board of directors

## Summary
- Nancy Davis, founder of Race to Erase MS and Cure Addiction Now, joins Tharimmune board effective August 4, 2025.
- Davis brings patient advocacy expertise and has raised over $56M for MS research through her foundation.
- Her appointment aligns with Tharimmune's focus on TH104 for opioid countermeasures and broader pipeline.
- Davis will serve until the 2026 annual meeting, with compensation consistent with other non-employee directors.

## SEC filing metadata
- accession: 0001641172-25-022615
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000164117225022615/0001641172-25-022615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000164117225022615/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022615
- JSON: https://secwatch.observer/filing/0001641172-25-022615.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022615.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.